Teva Pharmaceutical Industries Limited TEVA
$ 21.92
2.86%
Quarterly report 2024-Q3
added 11-06-2024
Country |
Israel |
IPO year |
- |
Industry |
Drug manufacturers |
Stock Exchange |
NYSE |
CEO |
Mr. Kre Schultz |
Employees in the company |
40 039 |
Shares |
1.12 B |
Market Cap[1] |
$ 24.5 B |
EBITDA (LTM) |
$ 1.14 B |
P/E (LTM) |
-14.56 |
P/S (LTM) |
1.21 |
EPS (LTM) |
-1.2 |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.